Skin Microbiota – A Novel Target for Promoting Burn Wound Healing

Review article discussing
the wound microbiome and Amicapsil

Treatment of venous leg ulcers with Amicapsil

“Amicapsil healed my venous leg ulcers and changed my life.”

“From 4 weeks of absolute hell – to being pain-free, getting a full night’s sleep and back to normal at work.”

“From 4 weeks of absolute hell, in pain 24 hours a day, struggling at work – to being pain-free, getting a full night’s sleep and back to normal at work.”

NH ( patient)

SertaSil for veterinary wound treatment

SertaSil for veterinary wound care

Effective in treating severe infections, including infections not responding to antibiotics and antiseptics.

Treatment of wounds and pressure ulcers in persons with spinal cord injury

Amicapsil-SCI

Effective treatment of wounds and pressure ulcers in SCI-persons and in controlling soft tissue infection caused by osteomyelitis.

Amicapsil treatment of acute stage 3 pressure ulcer

Amicapsil was used for the treatment of an infected acute grade 3 pressure ulcer on ischial tuberosity in a person with spinal cord injury.

At the time of starting treatment with Amicapsil, the pressure ulcer had been observed approximately two weeks earlier. The treatment use prior to Amicapsil-SCI was irrigation with saline, disinfection with Vashe, Medihoney in the wound bed, and covered with a Medipore dressing. Signs of a minor infection was present with the person running a temperature of 99-101F (37.2-38.3C) the past few days. The sore at start measured 1.5 cm x 2.5 cm.

Spinal cord injury interferes with the immune response and in addition a medication known to affect cell proliferation was taken. The interference of this medication with healing could be seen.

The infection in the wound included Serratia marcescens, an anaerobic multi-resistant bacterium, which produces a red toxin that inhibits the immune cells. The toxin can be seen as the red colour on the dressing Day 18.

After 77 days, Amicapsil treatment results in full closure of the acute stage 3 pressure ulcer.

MPPT is available as:

Wounds, ulcers and burns

Amicapsil for humans

Trauma and surgical wounds, pressure ulcers, venous leg ulcers, diabetic foot ulcers, burns, etc.

SertaSil for animals

Trauma and surgical wounds, abscesses, amputations, and burns in dogs, horses and other animals.

July 15’th, 2025 – New analysis published in Frontiers in Public Health questions whether antimicrobials play a major role in causing climate change.

New publication in Frontiers in Public Health: The contribution of antimicrobials and antimicrobial resistance to climate change and a possible

Amicapsil treatment of acute stage 3 pressure ulcer

MPPT is available as:

Wounds, ulcers and burns

Amicapsil for humans

SertaSil for animals

Dermatology

Aprobaxil for humans

Adinasil for animals

Related Posts

Amicapsil and Amicapsil-SCI on NHS Supply Chain

July 15’th, 2025 – New analysis published in Frontiers in Public Health questions whether antimicrobials play a major role in causing climate change.

Amicapsil and Amicapsil-SCI on NHS Supply Chain

July 15’th, 2025 – New analysis published in Frontiers in Public Health questions whether antimicrobials play a major role in causing climate change.

June 20’th, 2024 – Patient survey of MPPT published in Frontiers in Rehabilitation Sciences

January 5’th, 2024 – MPPT clinical study published in Frontiers in Medicine